 - Subjects of all races with clinical Stage IV cancer of any type, staged according to American Joint Commission on Cancer AJCC, sixth edition, who have no standard treatment options for the specific cancer Patients whose standard of care consists of watchful waiting and who fulfill the other eligibility criteria will be invited to participate. 